MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone... Show more

Profile

Industry
Pharmaceuticals Other
Address
101 Redwood Shores Parkway
Phone
+1 650 327-3270
Employees
730
Web
https://www.corcept.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.56B
P/E Ratio
227.74
Total Cash
338.18M
Projected Growth
N/A
Total Debt
9.64M
Revenue
769.1M
Risk (Beta)
0.28
Dividend Yield
N/A
Total Cash/Share
3.15
Total Debt/Equity
374.71
Revenue/Share
6.62 USD as % of share price
View a ticker or compare two or three
CORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
101 Redwood Shores Parkway
Phone
+1 650 327-3270
Employees
730
Web
https://www.corcept.com